Quick Answer
Exousia Bio, Inc. reported Stockholders Equity of $0.00 for fiscal year 2025.
Exousia Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $0.00 | +100.0% |
| 2024 | -$54.9K | -88.7% |
| 2023 | -$29.1K | -6556.3% |
| 2022 | -$437.00 | — |
| 2022 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $21.79M | +87570.6% | +61802.6% |
| August 31, 2025 | -$35.3K | +39.9% | — |
| May 31, 2025 | $0.00 | +100.0% | — |
| February 28, 2025 | $0.00 | +100.0% | -100.0% |
| November 30, 2024 | $24.9K | +155.5% | +142.3% |
| August 31, 2024 | -$58.8K | -42.6% | -7.1% |
| May 31, 2024 | -$54.9K | -88.7% | -10.6% |
| February 29, 2024 | -$49.6K | -83.3% | -10.8% |
- Exousia Bio, Inc. showed an increase of +100.0% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: